[1]
“Study on Prescription Technology of Sofosbuvir/Ledipasvir Tablet”, Commun. Comput. Chem., vol. 5, no. 3, pp. 86–95, Oct. 2018, doi: 10.4208/cicc.2017.v5.n3.4 .